Monograph Details
|
|
Dermatological Disorders
> Skin infections (topicals)
|
|
SSD |
| Manufacturer |
|
Par Pharmaceutical, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Sulfonamide antibacterial. |
| Generic Name |
|
Silver sulfadiazine 1%; crm. |
| Also |
|
• SSD AF
|
| Indications |
|
Prophylaxis and treatment of sepsis in 2nd and 3rd degree burns. |
| Children |
|
Not recommended. |
| Adults |
|
Apply 1–2 times daily aseptically to approximately 1/16 inch depth to cleansed and debrided burns. Reapply promptly if removed. Continue until wound is healed. May be occluded. |
| Contraindications |
|
Premature infants. Within first 2 months of birth. Late pregnancy. |
| Precautions |
|
G6PD deficiency. Impaired renal or hepatic function. Monitor serum sulfa levels and renal function in extensive burns. Pregnancy (Cat.B). Nursing mothers: not recommended. |
| Interactions |
|
Leukopenia increased with concomitant cimetidine. May inactivate debriding enzymes. |
| Adverse Reactions |
|
Transient leukopenia, skin necrosis, erythema multiforme, skin discoloration, burning sensation, rash, fungal overgrowth, interstitial nephritis, systemic sulfonamide reactions. |
| How Supplied |
SSD—25g, 50g, 85g, 400g
SSD AF—50g, 400g |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
